US 2014/0005256 A1Published application

Formulations with anti-tumour action

AssigneeGentium S.R.L.

InventorsLaura Iris FERRO, Massimo IACOBELLI, Paul RICHARDSON

Life of this patent

Estimating the term…

Formulations with anti-tumour action containing defibrotide and at least another active ingredient as active agents.

Dependent claims

A formulation containing, as active agents, defibrotide and at least another active ingredient with anti-tumour action.

Dependencies are inferred from the claim text.

A61K 31/711
Compounds having three or more nucleosides or nucleotides: natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to…
A61K 31/17
Amides, e.g. hydroxamic acids: having the group >N—C—N< or >N—C—N<, e.g. urea, thiourea, carmustine
A61K 31/195
Carboxylic acids, e.g. valproic acid: having an amino group
A61K 31/337
Having oxygen as the only ring hetero atom, e.g. fungichromin: having four-membered rings, e.g. taxol

From the US filing history. Foreign family members aren’t listed.

Loading patent…